Search
betamethasone dipropionate; betamethasone valerate (Celestone, Soluspan, Betasone)
Systemic agent: Tradename Celestone.
Indications:
1) skin disorders [4]
- seborrheic dermatitis, atopic dermatitis, neurodermatitis
- urticaria
- anogenital pruritus
- psoriasis
- inflammatory phase of xerosis
- late phase of allergic dermatitis or irritant dermatitis
- cutaneous T-cell lymphoma
- discoid lupus
- granuloma annulare
2) respiratory [4]
- bronchopulmonary dysplasia
- laryngeal edema
- respiratory distress syndrome
- bronchitis
- COPD
- Loeffler's syndrome
- masal polyp
- fetal lung maturation
3) neurologic [4]
- cerebral edema
- multiple sclerosis
4) hematologic [4]
- blood transfusion reaction
- Diamond-Blackfan syndrome
- autoimmune hemolytic anemia
- immune thrombocytopenic purpura
- thrombocytopenia
- angioneurotic edema
5) oncology [4]
- Hodgkin's disease
- non-Hodgkin's lymmphoma
- follicular lymphoma
- Mycosis fungoides
- multiple myeloma
- acute lymphoblastic leukemia
6) rheumatology [4]
- autoimmune disease
- systemic lupus erythematosus
- sarcoidosis
- serum sickness
- rheumatic fever, rheumatic heart disease, carditis
- muscle spasm
- bursitis
7) endocrine [4]
- congenital adrenal hyperplasia
- adrenogenital syndrome
- adrenal insufficiency
- hypercalcemia
8) GI [4]
- celiac sprue
- hepatic necrosis
9) renal [4]
- nephrotic syndrome
10) organ transplantation rejection [4]
11) inflammatory effects of infections [4]
a) trichinosis
b) tuberculosis
12) berylliosis
13) inflammatory eye disease
13) procedures
- dexamethasone suppression test [4]
Dosage:
1) 0.5-9.0 mg IM/PO QD
2) 12 mg IM QD x 2 doses (fetal lung maturation) Tabs: 0.6 mg Liquid: 0.6 mg/5 mL. Injection: 6 mg/mL, 5 mL vials.
also see topical betamethasone
Adverse effects:
1) common (> 10%)
- temporary mild blurred vision
- increased appetite
- indigestion
- insomnia
2) less common (1-10%)
- itching, burning, erythema, dryness, irritation, papular rashes, burning of eyes, burning of ears, cataracts, diabetes mellitus
3) uncommon (< 1%)
- hypertrichosis, acne, perioral dermatitis, maceration of skin, skin atrophy, striae, miliaria, hypertension, sudden blindness, convulsions, vertigo, confusion, headache, thin fragile skin, sterile abscess, hyperpigmentation, hypopigmentation, Cushingoid state, peptic ulcer, itching, muscle weakness, osteoporosis, glaucoma, sodium retention, impaired wound healing
4) miminal long-term (30 year) metabolic effects with antenatal exposure [3]
Drug interactions:
1) aminoglutethimide
2) anticholinesterases
3) barbiturates
4) carbamazepine
5) phenytoin
6) rifampin
7) live virus vaccines
Interactions
drug interactions
drug adverse effects (more general classes)
monitor with drug (more general classes)
Specific
Betamethasone Topical (Betatrex, Diprolene, Diprosone, Luxig foam, Valisone)
General
antipruritic agent
glucocorticoid
Properties
MISC-INFO: elimination route LIVER
pregnancy-category C
safety in lactation -
?
Database Correlations
PUBCHEM cid=9782
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
- Journal Watch 25(14):110, 2005
Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A,
Harding JE.
Cardiovascular risk factors after antenatal exposure to
betamethasone: 30-year follow-up of a randomised controlled
trial.
Lancet. 2005 May 28;365(9474):1856-62.
PMID: 15924982 [PubMed - in process]
- Dalziel SR, Liang A, Parag V, Rodgers A, Harding JE.
Blood pressure at 6 years of age after prenatal exposure to
betamethasone: follow-up results of a randomized, controlled
trial.
Pediatrics. 2004 Sep;114(3):e373-7.
PMID: 15342900
- Deprecated Reference
Component-of
betamethasone/bupivacaine/isopropanol/povidone iodine
betamethasone/calcipotriene (Enstilar)
betamethasone/clotrimazole (Lotrisone)
betamethasone/clotrimazole/gentamicin
betamethasone/gentamicin
betamethasone/gentamicin/isopropanol
betamethasone/isopropanol/lidocaine/povidone iodine
betamethasone/sodium phosphate